EUVIMEDEUVIMED entdecken
Crossref

Mitochondrial remodeling as a effector of glp-1 therapy in obesity and diabetes: review

Yosra Alhindi

Journal of Advanced Pharmacy Education and Research · 2026 · 16 (1) · 201-210

DOI: 10.51847/bfye5lnqza ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Advanced Pharmacy Education and Research, 2026. Verfasst von Yosra Alhindi. Die Arbeit nennt 109 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Alhindi, Y. (2026). Mitochondrial remodeling as a effector of glp-1 therapy in obesity and diabetes: review. Journal of Advanced Pharmacy Education and Research, 16(1), 201-210. https://doi.org/10.51847/bfye5lnqza

Vancouver

Alhindi Y. Mitochondrial remodeling as a effector of glp-1 therapy in obesity and diabetes: review. Journal of Advanced Pharmacy Education and Research. 2026;16(1):201-210. doi:10.51847/bfye5lnqza

BibTeX
@article{Alhindi2026,
  author = {Alhindi, Yosra},
  title = {Mitochondrial remodeling as a effector of glp-1 therapy in obesity and diabetes: review},
  journal = {Journal of Advanced Pharmacy Education and Research},
  year = {2026},
  volume = {16},
  number = {1},
  pages = {201--210},
  doi = {10.51847/bfye5lnqza}
}
Kostenlos starten →